Filter Results:
(4,962)
Show Results For
- All HBS Web
(4,962)
- People (16)
- News (1,906)
- Research (2,472)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,883)
Show Results For
- All HBS Web
(4,962)
- People (16)
- News (1,906)
- Research (2,472)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,883)
- Web
Drug & Alcohol Policy | About
Harvard’s Employee Assistance Program (EAP). The Harvard University Police Department brochure Playing It Safe contains helpful information as well. Additionally, any member of the University may make use of the Health Services on an... View Details
- Web
Social Progress Imperative - Institute For Strategy And Competitiveness
HBS ISC About Michael Porter About Michael Porter A Letter from Michael Porter Biography The Essential Porter Honors & Awards Affiliated Organizations & Institutions VBHCD Initiative Affiliated Organizations... Affiliated Organizations & Institutions ICHOM VBHCD... View Details
- 21 Feb 2023
- Research & Ideas
Are Your Employees Passing Up Incentives? Try Promoting the Programs More
tested their idea through a 2015 field experiment that involved 2,500 participants in a walking program offered by the Evidation health tracking platform. The program paid the walkers small amounts of money based on their total steps. “We... View Details
Keywords: by Scott Van Voorhis
- November 2022 (Revised April 2024)
- Case
Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams
By: Debora L. Spar and Julia M. Comeau
In 1990, satellite expert and Sirius XM founder Martine Rothblatt was determined to save the life of her seven-year-old daughter, Jenesis, who was diagnosed with a terminal illness called Pulmonary Arterial Hypertension (PAH). At the time, there was little medication... View Details
Keywords: Pharmaceutical Companies; Technological And Scientific Innovation; Organ Donation; Health Care and Treatment; Health Disorders; Innovation and Invention; Pharmaceutical Industry; Medical Devices and Supplies Industry; United States; District of Columbia
Spar, Debora L., and Julia M. Comeau. "Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams." Harvard Business School Case 323-039, November 2022. (Revised April 2024.)
- 25 Jan 2010
- Research & Ideas
A Macroeconomic View of the Current Economy
course, was a careful student of the Great Depression; he understood it quite well, particularly from a monetary standpoint. The level of monetary understanding is much better than it was in the past. And that reduces our odds of falling... View Details
Keywords: by Sean Silverthorne
- 17 Nov 2016
- Op-Ed
What's Behind the Unexpected Trump Support from Women
higher education His stand on workplace deregulation raises concerns about continued protection of women’s (and men’s) human and civil rights A reshaped Supreme Court could roll back protections to the rights of women, including the right to choose Changes to the... View Details
Keywords: by Laura Morgan Roberts and Robin Ely
- 30 Jul 2007
- Research & Ideas
Repugnant Markets and How They Get That Way
cockroaches in California, because nobody wants to eat cockroaches. The law of supply and demand takes care of that. But the reason there's a law against eating horse meat in California is because some people would like to eat horse meat,... View Details
Keywords: by Martha Lagace
- Research Summary
Overview
My academic research centers on uncovering and closing gaps between the theory and reality of tax policy. My main contribution has been to identify and address a mismatch between the goals for taxation typically assumed in theory and the goals the public and... View Details
- 25 Aug 2014
- News
Ashraf M. Dahod, MBA 1981
support for education and health care—particularly for underserved populations—can be seen in the Boston area as well as in Mumbai, where the couple met as teenagers. Working with Shamim, a medical doctor who has survived two bouts with... View Details
Keywords: Susan Young
- 20 Apr 2020
- Blog Post
Introducing LivelyHood, A Volunteer Nonprofit Founded in Response to COVID-19
thereafter, the world started to change quickly and dramatically. The impending health crisis and mass stockpiling consumed the collective psyche. And a tweet from the UK went viral: a nurse who had worked all day taking View Details
- 28 May 2019
- Research & Ideas
Investor Lawsuits Against Auditors Are Falling, and That's Bad News for Capital Markets
dismissals have increased, and settlements in recent years have declined,” conclude the authors of a new research paper. “Our study asks why.” The number of lawsuits specifically about Rule 10b-5, the antifraud regulation created under... View Details
- 22 Feb 2022
- News
Breaking News
benefit corporation. There are many ways that we can combine the structure and strategy and capital to get to local ownership. But ultimately, this has to work for the people who care about this in Colorado. We’re facilitating that... View Details
- Web
ICIC - Institute For Strategy And Competitiveness
HBS ISC About Michael Porter About Michael Porter A Letter from Michael Porter Biography The Essential Porter Honors & Awards Affiliated Organizations & Institutions VBHCD Initiative Affiliated Organizations... Affiliated Organizations & Institutions ICHOM VBHCD... View Details
- 01 Oct 2013
- First Look
First Look: October 1
champions that the government hoped to create, SPH was also considering an acquisition in the U.S. or Europe. This case allows students to consider the broad trends sweeping China's pharmaceutical industry and health View Details
Keywords: Sean Silverthorne
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- 01 Jun 2008
- News
You Only Thought You Were Republican
capitalists like Warren Buffett, a hero to many of us, support the Democratic Party. (Warren did two fundraisers for Hillary, two for Barack, one for the Democratic Senatorial Campaign Committee, and, I am ever so pleased to say, one for the DNC.) How are your... View Details
- November 2019
- Case
The Genesis Lab at Novartis
By: Amy C. Edmondson, Ranjay Gulati, Patrick J. Healy and Kerry Herman
Novartis' Genesis Labs program, launched in 2016 as part of Novartis Institutes for Biomedical Research (NIBR), hosted pitch competitions where teams of NIBR scientists proposed ideas to explore that aimed to revolutionize drug discovery. The goal was to break down... View Details
Keywords: Drug Discovery; Health Care and Treatment; Research and Development; Innovation and Invention; Programs; Management
Edmondson, Amy C., Ranjay Gulati, Patrick J. Healy, and Kerry Herman. "The Genesis Lab at Novartis." Harvard Business School Case 620-007, November 2019.
- 01 Jun 2020
- News
Vital Signs
Halle Tecco (MBA 2011) Halle Tecco (MBA 2011) Halle Tecco (MBA 2011) has been a health care investor since she graduated from HBS. Her fascination with the massive disruptions underway in the industry led... View Details
- 23 Mar 2023
- News
Winners Crowned in 2023 Alumni New Venture Competition
Alumni-founded startups M7 Health and Hue came out victorious in the 2023 Alumni New Venture Competition on Thursday, winning the Grand Prize and Runner Up awards respectively in an impressive field of eight global regional winners.... View Details